In a report released today, Robert LeBoyer from Noble Financial reiterated a Buy rating on MAIA Biotechnology, Inc. (MAIA – Research Report), ...

Health-care companies rose as a reported U.S. death from bird flu stoked fears of a new pandemic, boosting shares of vaccine makers.

MAIA Biotechnology's shares rose 19% to $2.46 after the company said it entered into a clinical supply agreement with BeiGene to evaluate THIO, MAIA's telomere-targeting anticancer agent.

MAIA Biotechnology (MAIA) announced that it has entered into a clinical supply agreement with BeiGene (BGNE) to assess the efficacy of THIO, ...

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications ...

Bangalore (Karnataka) [India], December 27: Biotechnology, a transformative field at the crossroads of science and technology, continues to revolutionize industries globally. From healthcare to ...

Brazilian world number 17 Beatriz Haddad Maia was forced to serve under-arm as cramps rendered her glued to the spot in a remarkable three-hour 22-minute epic on day one of the United Cup in Perth.

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United ...

MAIA Biotechnology (NYSEAMERICAN:MAIA – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th.The company reported ($0.11) earnings per share (EPS) for the quarter ...

Morningstar brands and products Company Portfolio ...